Plasma YKL-40 levels in healthy subjects from the general population

Stig E Bojesen; Julia S Johansen; Børge G Nordestgaard

doi:10.1016/j.cca.2011.01.022

Plasma YKL-40 levels in healthy subjects from the general population

Stig E Bojesen, Julia S Johansen, Børge G Nordestgaard

Research output: Contribution to journal › Journal article › Research › peer-review

110 Citations (Scopus)

Abstract

Plasma YKL-40 is a new biomarker in patients with cancer and inflammatory diseases. High plasma YKL-40 is associated with poor prognosis. Our aim was to determine reference levels in healthy subjects.

Original language	English
Journal	Clinica Chimica Acta
Volume	412
Issue number	9-10
Pages (from-to)	709-12
Number of pages	4
ISSN	0009-8981
DOIs	https://doi.org/10.1016/j.cca.2011.01.022 https://doi.org/10.1016/j.cca.2011.01.022
Publication status	Published - 11 Apr 2011

Access to Document

Cite this

@article{2485617c48064d8b8148bd22f60717df,

title = "Plasma YKL-40 levels in healthy subjects from the general population",

abstract = "Plasma YKL-40 is a new biomarker in patients with cancer and inflammatory diseases. High plasma YKL-40 is associated with poor prognosis. Our aim was to determine reference levels in healthy subjects.",

author = "Bojesen, {Stig E} and Johansen, {Julia S} and Nordestgaard, {B{\o}rge G}",

year = "2011",

month = apr,

day = "11",

doi = "10.1016/j.cca.2011.01.022",

language = "English",

volume = "412",

pages = "709--12",

journal = "Clinica Chimica Acta",

issn = "0009-8981",

publisher = "Elsevier",

number = "9-10",

}

TY - JOUR

T1 - Plasma YKL-40 levels in healthy subjects from the general population

AU - Bojesen, Stig E

AU - Johansen, Julia S

AU - Nordestgaard, Børge G

PY - 2011/4/11

Y1 - 2011/4/11

N2 - Plasma YKL-40 is a new biomarker in patients with cancer and inflammatory diseases. High plasma YKL-40 is associated with poor prognosis. Our aim was to determine reference levels in healthy subjects.

AB - Plasma YKL-40 is a new biomarker in patients with cancer and inflammatory diseases. High plasma YKL-40 is associated with poor prognosis. Our aim was to determine reference levels in healthy subjects.

U2 - 10.1016/j.cca.2011.01.022

DO - 10.1016/j.cca.2011.01.022

M3 - Journal article

VL - 412

SP - 709

EP - 712

JO - Clinica Chimica Acta

JF - Clinica Chimica Acta

SN - 0009-8981

IS - 9-10

ER -